The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations by Henken, Florianne E. et al.
ORIGINAL PAPER
The functional role of Notch signaling in HPV-mediated
transformation is dose-dependent and linked to AP-1
alterations
Florianne E. Henken & Johanna De-Castro Arce &
Frank Rösl & Leontien Bosch & Chris J. L. M. Meijer &
Peter J. F. Snijders & Renske D. M. Steenbergen
Accepted: 18 September 2011 /Published online: 24 January 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract
Background The role of Notch signaling in HPV-mediated
transformation has been a long standingdebate, as bothtumor
suppressive and oncogenic properties have been described.
We examined whether the dual findings in literature may be
explained by gene dosage effects and determined the relation
with AP-1, a downstream target of Notch.
Methods SiHa cervical cancer cells were transfected with
two doses of intracellular active Notch. Non-tumorigenic
HPV16-immortalized keratinocytes (FK16A) were trans-
fected with Fra1 specific siRNAs and non-targeting
controls. Transfectants were analysed for Notch, Hes, cJun,
cFos and Fra1 mRNA expression, Notch pathway activa-
tion using luciferase assays, cell viability using MTT
assays, anchorage independent growth, AP-1 activity and/
or AP-1 complex composition using EMSA.
Results In SiHa cells two activation states of Notch
signaling pathway were obtained. Moderate Notch activa-
tion contributed to increased viability and anchorage
independent growth, whereas high level Notch activation
decreased anchorage independent growth. The shift in
phenotypical outcome was correlated to altered AP-1
activity and complex composition. Moderate Notch expres-
sion led to an increased AP-1 transcriptional activity and
DNA binding activity, but did not affect complex compo-
sition. High levels of Notch additionally led to a change in
AP-1 complex composition, from cJun/cFos to cJun/Fra1
dimers, which is exemplary for non-tumorigenic HPV-
immortalized cell lines. Conversely, silencing of Fra1 in
non-tumorigenic HPV16-immortalized keratinocytes, lead-
ing to an enrichment of cJun/cFos dimers, was accompa-
nied with increased colony formation.
Conclusion The functional role of Notch in HPV-mediated
transformation is dosage dependent and correlated to a
change in AP-1.
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1 Introduction
Sustained expression of the human papilloma virus (HPV)
oncogenes E6 and E7 is necessary to acquire and maintain
the transformed state of cervical cancer and its high grade
precursor lesions. However, additional cellular alterations
are required for the progression of HPV-containing precur-
sor lesions towards cervical cancer. Several studies indicate
the involvement of aberrant Notch signaling in the process
of cervical carcinogenesis [3, 6, 10, 15, 16, 18, 19, 21].
Notch plays a role in multiple cellular processes, such as
differentiation, proliferation and apoptosis (reviewed by
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family members, the transmembrane receptor Notch is
conformationally changed which allows proteolytic cleav-
age and release of the intracellular part of Notch (ICNX).
After translocation to the nucleus, intracellular Notch
competes with repressor proteins for binding the transcrip-
tion factor C-promoting binding factor 1 (CBF1). Binding
of ICNX to CBF1 leads to recruitment of coactivators
which turn CBF1 from a transcriptional repressor into an
activator, mainly targeting the transcription family Hairy
enhancer of split (Hes).
In cervical cancer, both tumor suppressive as well as
oncogenic properties of Notch signaling have been described.
Some studies report undetectable Notch levels in cervical
cancer cell lines and reduced expression in cancer specimens.
In these studies Notch overexpression has tumor suppressive
effects, such as growth inhibition and induction of apoptosis
[15, 16, 18]. Others have demonstrated that increased Notch
expression correlates with progression to cervical cancer [3,
9, 21] and contributes to transformation by signaling for
survival [10, 19]. At least part of the discrepancies in
functional studies may be explained by dosage effects, as it
has been previously shown that high Notch levels reduced
proliferation and HPV promoter activity in cervical cancer
cells, whereas moderate Notch expression levels enhanced
transformation of HPV transfected keratinocytes [6].
One of the downstream effectors of Notch is the AP-1
transcription factor complex. This is a dimeric complex
consisting of both Jun family members (cJun, JunD, JunB)
and Fos family members (Fra1, Fra2, cFos, FosB) [5]. The
AP-1 complex can bind to the TPA response element
(TRE), thereby regulating gene transcription. Genes con-
taining such elements are involved in various cellular
processes such as differentiation, proliferation and apopto-
sis. The effect of AP-1 on gene expression depends on the
dimerization partners, the promoter and other transcription
factors involved, as well as the cell type analysed. AP-1 is
also involved in transcriptional regulation of HPV, as the
upstream regulatory region (URR) of HPV harbors AP-1
binding sites in the promoter and enhancer region [11, 17].
Moreover, AP-1 complex composition appears phenotype
dependent in HPV-containing cells. Whereas tumorigenic
cervical cancer cells like SiHa and HeLa were found to
contain cJun/cFos dimers, non tumorigenic HeLa-fibroblast
hybrids as well as non-tumorigenic HPV-immortalized
keratinocytes displayed cJun/Fra1 dimers [11, 12, 20].
In previous work, we demonstrated that an altered AP-1
compositionseenbetweennon-tumorigenicHPV-immortalized
keratinocytes and tumorigenic cervical cancer cells was
associated with a change in Notch mRNA expression [20].
Notch expression levels progressively increased with hrHPV-
mediated immortalization of primary keratinocytes in vitro.
However, Notch expression was strongly reduced in cervical
cancer cell lines SiHa and HeLa [20] .T h ef a c tt h a tN o t c h
expression increases during early stages of transformation but
is reduced in cancer cell lines, suggests that its functional
effects may be dose-dependent. In the present study we aimed
to investigate the dosage dependent functional effects of
Notch in HPV-containing cells andt od e t e r m i n et h er e l a t i o nt o
AP-1.
2 Material and methods
2.1 Cell culture, transfection and luciferase assays
Cervical cancer cell line SiHa was obtained from the
American Type Culture Collection (Manasas, VA, USA) and
cultured in DMEM supplemented with 10% fetal calf serum,
penicillin (100U/ml), streptomycin (100 μg/ml), and L-
glutamine (2 mM). HPV16-immortalized keratinocytes
(FK16A) were cultured in serum-free keratinocyte medium
(Invitrogen, Breda, The Netherlands), as described previously
[14]. Transfections were performed using Lipofectamine
(Invitrogen) or Dharmafect2 (Dharmacon, Lafayette, Louisi-
ana, USA) for cDNA and siRNA respectively, according to
the manufacturers instructions. cDNA encoding the intracel-
lular part of Notch was a kind gift from dr. Warren Pear
(Department of Pathology, University of Pennsylvania,
Philadelphia, USA) and was cloned into pcDNA3.1hygro
expression vector (Invitrogen). Moderate Notch expression
levels were obtained by transfecting according to manufac-
turers instructions (4 μgD N A / 2 5 0 0μlm e d i u m / 6w e l l ) .
High expression levels of Notch were created by increasing
the concentration of transfection mixture 5 times (4 μg
DNA/500 μl medium/6 well). Empty vector was used in
both concentrations as a control. A pool of Fra-1 specific
siRNAs was used to silence Fra1 (#L-004341-00-0005,
Dharmacon). A pool of 4 non-targeting siRNAs (#D-
001810-10-05, Dharmacon) was used as negative control.
The use of a non-targeting siRNA pool ensures control for
off-target effects. The luciferase construct for Hes1 was
kindly provided by dr. Marc Vooijs (Department of
Pathology, University Medical Center Utrecht, The Nether-
lands) and URR-luciferase was obtained from Dr. Felix
Hoppe-Seyler (Department of Molecular Therapy of Virus-
Associated Cancers, German Cancer Research Center, Heidel-
berg, Germany). Firefly luciferase and Renilla luciferase were
measured using Dual Luciferase assay (Promega, Wisconsin,
USA).
2.2 RNA isolation and RT-PCR
mRNA was isolated using RNA-B reagent (Tel-Test,
Friendswood, TX, USA). Isolated RNA was DNase treated
using RQ1 RNase-free DNase (Promega, Madison, WI,
78 F.E. Henken et al.USA) and used for cDNA synthesis with a specific reverse
primer. Quantitative RT-PCR for AP-1 family members was
performed as described previously using primers and
probes as shown in Table 1 [20]. To correct for RNA
quality and input, we performed RT-PCR for the house-
keeping gene snRNP U1A. For quantification purposes a
standard curve was made of serial dilutions of cell line
cDNA of cell lines highly expressing the target (primary
keratinocytes, FK16A or SiHa) synthesized with the
respective specific reverse primers. Notch and Hes1 RT-
PCRs were performed using SYBR Green PCR Master Mix
(Applied Biosystems, Carlsbad, CA, USA) and AP-1
member RT-PCRs were performed using Universal PCR
Master Mix (Applied Biosystems).
2.3 EMSA
Nuclear extracts were prepared as described previously [2].
Protein concentration was determined using the BCA
protein assay kit from Pierce (Thermo Fisher Scientific,
Rockford, IL, USA). AP-1 consensus oligonucleotide was
generated in an Applied Biosystems synthesizer using
phosphoramitide chemistry and further purified by HPLC.
The annealed oligonucleotide was labeled with [γ-
32P]ATP
(Amersham, 3000 Ci/mmol) using T4 polynucleotide
kinase and purified from a 15% polyacrylamide gel. The
binding reaction was performed as described before [4].
After 30 min incubation at room temperature, 2 μgo f
specific antibody was added and incubated at 4°C for 1 h.
The antibody used for cJun was sc822x, for Fra1 sc605x
and for cFos sc52x (all from Santa Cruz Biotechnology Inc,
Santa Cruz, USA). The complexes were separated on 5.5%
nondenaturing polyacrylamide gels by running 30 min at
280 V and 75 min at 350 V.
2.4 Viability and anchorage independent growth
Cell viability was assessed by MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) dye reduction (ICN
Biomedicals Inc, OH, USA). Cells were seeded in triplicate
wells in 96-wells plates after transfection and measured after
5 days in culture. Control conditions were set to 100%.
To examine anchorage independent growth under the
different conditions 5000 cells were plated in semi-solid
agarose as described before [13]. After 3 weeks colonies
exceeding ~50 cells were counted and pictures taken.
2.5 Statistical analysis
All statistical analyses were carried out using the T-test in
Excel. A p-value ≤0.05 was considered statistically significant.
3 Results
3.1 Dose-dependent effects of ectopic Notch expression
in SiHa cervical cancer cells
To analyze the potential dose dependent effects of Notch in
HPV-induced transformation, moderate and high levels of
ectopic Notch expression were examined in the cervical
cancer cell line SiHa, which is known to have reduced
Notch levels [20]. Towards this end two different concen-
trations of cDNA encoding the intracellular active form of
Notch (ICNX) were transfected in SiHa cells, referred to as
moderate and high. Moderate ICNX concentrations resulted
in 46 times increased Notch mRNA expression and
transfection of high concentrations of ICNX resulted in
191 times increased Notch mRNA expression (Fig. 1a).
To next examine the dose-dependent effect of Notch
overexpression on pathway activation, co-transfections of
ICNX and luciferase constructs driven by the Hes1
promoter were performed in SiHa cells. Figure 1b shows
that Notch induced Hes1 transcription in a dose-dependent
manner from 15-fold to 34-fold compared to untransfected
controls in cells with moderate and high Notch, respective-
ly. Also Hes1 mRNA expression was increased in Notch
transfectants, confirming functional Notch activity. How-
ever, no difference in Hes1 mRNA levels was observed
between cells with moderate and high Notch (Fig. 1c),
suggesting that regulatory mechanisms other than those
measured by reporter assays, such as chromatin and post-
transcriptional modifications, may refrain Hes1 mRNA
expression from being further upregulated.
Table 1 Primer and probe sequences used in RT-PCR
Target Forward sequence 5′ -3 ′ Reverse sequence 5′-3 ′ Probe 5′-3 ′
ICNX TCCACCAGTTTGAATGGTCA CGCAGAGGGTTGTATTGGTT
Hes1 AGAAAGATAGCTCGCGGCATT GGTGCTTCACTGTCATTTCCA
cJun TGGGAGGACCGGAGACAAG AAGCCTAAGACGCAGGAAAGG CAGAGTCCCGGAGCCAACTTTTGCA
Fra1 TGCCACCCTAGCCAATGTCT TGGAGTTGGATGTGGGATACTG CCTTCCCCCACCGGTCCAGC
cFos AATCCGAAGGGAAAGGAATAAGA GTCTCCGCTTGGAGTGTATCAGT CTGCAGCCAAATGCCGCAACC
snRNP TCCTCACCAACCTGCCAGA TGAAGCCAGGGAACTGATTGA AGACCAACGAGCTCATGCTGTCCATG
Dosage-dependent Notch signaling in HPV-mediated transformation 79Todetermine thefunctionalconsequencesofectopic Notch
expression SiHa cells transfected with the two ICNX
concentrations and corresponding empty vector concentra-
tions were assayed for cellular viability using an MTT assay
and anchorage independent growth. Moderate Notch expres-
sion resulted in a significantly higher cell viability compared
to empty vector control cells (p=0.0002). Conversely, high
Notch expression did not alter cell viability (Fig. 2a). Colony
formation was altered in different ways at both conditions;
moderate levels of Notch increased the colony forming
capacity (not significant), whereas high expression levels of
Notch resulted in a significantly reduced colony forming
capacity (p=0.05) (Fig. 2b).
3.2 Effects of Notch on AP-1 transcription, activity
and composition are dose-dependent
Next, we determined transcriptional activity of AP-1, a well
known downstream target of Notch signaling, upon Notch
overexpression. Co-transfection experiments of ICNX cDNA
and a TPA response element (TRE) driven luciferase
construct, the latter allowing to measure AP-1 activity,
revealed that AP-1 activity was induced in a dose-dependent
manner (Fig. 3a).
Whereas AP-1 can bind to TPA response elements also
transcription of AP-1 members itself is regulated by these
TREs. To determine whether increasing levels of Notch
expression affected mRNA expression of AP-1 family
members, quantitative RT-PCR for different family members
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Fig. 2 Functional effects of moderate and high Notch overexpression
in SiHa cells. a Cellular viability measured by MTT assay. The Y-axis
indicates the relative cellular viability following 5 days in culture.
Control transfections were set to 100% b Quantification of anchorage
independent growth, in which the number of colonies was counted
after 3 weeks in culture. Control transfections were set to 100%. (*)
Indicates significant differences compared to control transfections
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Fig. 1 Dose-dependent effect of Notch expression in SiHa cells. a
Notch mRNA expression levels upon transfection of two concen-
trations of transfection mix. ev: empty vector control b Relative
luciferase activity of Hes1 responsive luciferase reporter plasmid in
SiHa cells transfected with two doses of Notch compared to
untransfected (untf) cells. c Messenger RNA expression of the
downstream target of Notch signaling, Hes1. ev: empty vector control
80 F.E. Henken et al.was performed (Fig. 3b). Induction of moderate Notch
overexpression resulted in increased mRNA expression of
cJun, while cFos and Fra1 mRNA expression were not
markedly altered. Upon high Notch expression, cJun mRNA
was still increased, but to a lower level compared to
moderate Notch expression. Also a slight increase in cFos
mRNA was seen, whereas Fra1 mRNA expression remained
unchanged.
To determine whether Notch overexpression was correlated
to altered AP-1 DNA binding activity and complex composi-
tion Electrophoretic Mobility Shift Assays (EMSAs) were
performed. As shown in the empty vector control transfectants
(Fig. 3c, left panel), the AP-1 complexes in SiHa cells consist
of cJun/Fra1, cJun/cFos and possibly also cJun/cJun dimers.
After inducing a moderate level of Notch expression, an
increased DNA binding was observed (Fig. 3c, compare lane
5 with lane 1), indicating elevated AP-1 activity, in line with
the luciferase assays (Fig. 3a). However, no change in
composition was seen. Strikingly, cells with high expression
levels of Notch displayed no visible increase in DNA binding
activity though the cFos signal was decreased and the Fra1
signal was increased, indicating a shift in complex compo-
sition towards cJun/Fra1. This change is likely to reflect a
functionally altered AP-1 complex as an increase in cJun/
cFos dimers in the AP-1 complex is associated with a
tumorigenic phenotype, while a complex primarily consisting
of cJun/Fra1 dimers is linked to a non-tumorigenic state
[11, 20].
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Fig. 3 Effect of moderate and high Notch expression on AP-1
activity, AP-1 member mRNA expression and complex composition. a
Relative luciferase activity of a TPA-response element (TRE) -
responsive luciferase reporter plasmid in SiHa cells transfected with
moderate and high levels of Notch compared to untransfected (untf)
controls (set to 1). b mRNA expression of AP-1 family members cJun,
Fra1 and cFos upon moderate and high Notch expression compared to
cells transfected with empty vector (set to 1). c EMSA performed
using nuclear extracts of SiHa transfected with empty vector DNA,
moderate and high levels of Notch cDNA. Specific antibodies were
used to obtain supershifts for the different components
Dosage-dependent Notch signaling in HPV-mediated transformation 813.3 Silencing Fra1 in HPV16-immortalized keratinocytes
alters AP-1 and increases anchorage independent growth
Human foreskin keratinocytes immortalized by full length
HPV16 posses an AP-1 complex consisting of cJun/Fra1 and
are non-tumorigenic [20]. To examine the functional conse-
quence of altered AP-1 complexes in HPV16-immortalized
cells we depleted Fra1 in immortal FK16A cells (passage
156) by transfecting a pool of siRNAs targeting Fra1 or non-
targeting siRNAs as control.
Fra1 silencing resulted in an upregulation of cFos
mRNA and had little effect on cJun mRNA expression
(Fig. 4a). Examination of AP-1 complex composition in
these cells showed that silencing of Fra1 resulted in a
reduced Fra1 incorporation into the complex, with more
cJun/cFos dimers being the consequence (Fig. 4b). HPV16-
immortalized keratinocytes silenced for Fra1 displayed
increased colony forming capacity in soft agarose (Fig. 4c)
without an increase in proliferative potential (not shown). No
effects were seen using non-targeting siRNAs on complex
composition, proliferation or anchorage independent growth.
These results further strengthen the notion that changes in
AP-1 complex composition are important in HPV-mediated
transformation.
4 Discussion
The dual findings on the role of Notch signaling in cervical
carcinogenesis have been a long standing debate. Recently,
a model has been proposed by Maliekal et al., suggesting
that the opposing effects described in literature are dosage
dependent [7]. This model was based on the application of
a single dose of Notch expression in individual cell lines
with different outcomes in the different studies [15, 16, 18,
19] and on the effects of two levels of Notch over-
expression in HeLa cells and HaCat cells, respectively, on
DNA synthesis and HPV promoter activity [6]. However,
there has been no direct proof for this concept. Here, we
analysed this hypothesis directly by studying the effects of
two Notch expression levels on several phenotypes in the
same cell line. Two expression levels of intracellular active
Notch were created leading to two activation states of the
signaling pathway, as confirmed using Hes luciferase
assays, in the cervical cancer cell line SiHa. While
moderate Notch activation contributed to increased viability
and anchorage independent growth properties, high level
Notch activation exhibited tumor suppressive traits, e.g.
reduced colony formation. Hence, these findings nicely
confirm the model as proposed by Maliekal et al., and
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Fig. 4 The effect of Fra1 silencing in HPV16-immortalized keratino-
cytes. a mRNA expression of AP-1 family members Fra1, cFos and
cJun upon transfection with siRNAs targeting Fra1 or a non-targeting
siRNA control. b EMSA for AP-1 composition using cells transfected
with siRNAs targeting Fra1 compared to non-targeting control. The
lower band is total AP-1 bound to the consensus oligo. Arrows
indicate specific antibody supershifts. c Colony formation in soft
agarose. Transfection with siRNAs targeting PLK1 which induces cell
death was included as a control for transfection efficiency
82 F.E. Henken et al.provide at least in part an explanation for the controversial
data published previously. Moreover, we showed that the
dual findings in phenotypical outcome upon moderate and
high Notch expression may be explained by a switch in
composition of the transcription factor AP-1, a well known
downstream target of Notch signaling. In tumorigenic SiHa
cells, cJun/cFos heterodimers are more prominent than in
non-tumorigenic HPV-immortalized cell lines. Increasing
Notch activation to moderate levels in these cells increased
AP-1 activity, as measured using TRE-driven luciferase,
and DNA binding, as seen in EMSAs, though did not affect
complex composition. High level Notch activation, on the
other hand, led to a change in the composition of AP-1,
towards cJun/Fra1.
The correlation between Notch and AP-1 family member
expression and function has been the subject of several
studies, though has not yet been analysed in the context of
AP-1 complex composition. It has been demonstrated that
Notch overexpression in HeLa cells resulted in increased
protein expression of cJun [18], which is in line with the
presently observed increase in mRNA expression upon
moderate Notch expression in SiHa cells. However, Notch
overexpression was previously found to decrease the
expression of cFos in HeLa cells [15, 16, 18], and linked
to decreased AP-1 activity [18]. This is in contrast to
present findings in which AP-1 activity was increased upon
both moderate and high Notch expression, whereas also c-
Fos mRNAwas slightly increased. On the other hand, in the
study by Talora et al., AP-1 activity was not affected upon
Notch overexpression in SiHa, HeLa and CaSki cells [15].
Therefore, the absence of concordance between the various
studies on Notch and AP-1 activity, indicates that neither
expression of individual AP-1 members, nor sole AP-1
activity measured by reporter-assays can explain the link
between AP-1 and Notch in HPV-mediated transformation,
and that also complex composition should be taken into
account.
The importance of complex composition with respect to
phentoypical outcome has been demonstrated in HPV16-
immortalized keratinocytes in which cJun/Fra1 complexes
are prominent [20]. Silencing of Fra1 using siRNAs
reduced AP-1 DNA binding activity and reduced Fra1
incorporation in EMSA, while colony formation was
increased. The resulting enrichment of cJun/cFos dimers
led to increased anchorage independent growth properties.
These results are in line with those described by Soto et al.,
for HeLa cells [12].
Part of the discrepancies in literature may also be related
to the cell lines used. CaSki cells express much higher
levels of both Notch and Fra1 compared to SiHa and HeLa
cells [20]. Notch expression appeared essential for the
tumorigenic phenotype of CaSki cells, as Notch silencing
was growth inhibitory [19]. On the other hand, exaggerated
levels of Notch had detrimental effects on growth and
survival of HeLa [6, 18], similar to our findings in SiHa
cells. How Notch expression and activity is regulated is not
completely understood. Several lines of evidence indicate
that HPV E6E7 expression may upregulate Notch expres-
sion in primary cells [6, 19] as was also seen in our
previous study showing increased Notch mRNA expression
in HPV-immortalized cells compared to primary keratino-
cytes [20]. On the other hand E6E7 expression itself also
appears to be regulated by Notch, most likely mediated by
AP-1 [6, 16, 18]. Additionally, Notch activity is known to
depend on ligand availability on neighboring cells
(reviewed by [1, 8]). Interestingly, both Jagged and Delta-
like 1 ligands, which regulate Notch signaling, show the
same expression profile as Notch at the different stages of
transformation, i.e. increased in HPV-immortalized cells and
reducedincancercelllines(datanotshown),andmaytherefore
contribute to Notch regulation in the HPV-containing cells.
Based on present findings and literature data we
conclude that during early stages of transformation, i.e.
from mortal primary cells, to HPV-immortalized cells and
anchorage independent cells, Notch expression rises, to aid
the early steps in transformation, while after accomplish-
ment of transformation Notch expression is downregulated,
apparently to stimulate events inducing tumorigenicity. We
furthermore demonstrated that Notch functioning is dose
dependent, with a moderate dose inducing transformation
and a high dose inducing a change in AP-1 composition in
favour of cJun/Fra1 dimers, leading to reduction of
anchorage independent growth.
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